Press Release – Medicines New Zealand Medicines New Zealand believes that strong intellectual property protections are necessary for the discovery and development of new treatments and therapies for New Zealand patients, including innovative biologic medicines. The limitation placed …
Trans-Pacific Partnership: A Mixed Bag for NZ Patients Read More »
Press Release – Medicines New Zealand Medicines New Zealand Statement on the Trans-Pacific Partnership Negotiations 6 October 2015 Medicines New Zealand believes signing of the TPP has potential to boost the New Zealand economy by between $2-4 billion per year, open up new markets for …
Medicines New Zealand Statement on the TPP Read More »
Press Release – Medicines New Zealand New Zealand’s innovative companies and research community must protect their breakthroughs, for the country to continue to grow its science based economy, a group of visiting IP and investment experts say. Joseph Damond, Senior Vice President (International), …
Capturing Value from Innovation Vital for NZ Read More »
Press Release – Medicines New Zealand Providing solutions to help New Zealand’s health system better serve its people is at the heart of Medicines New Zealand’s message at the Trans Pacific Partnership meetings in Dallas this week. In a speech delivered to a stakeholder meeting in Dallas, …
Improved Access to Innovative Medicines Good for NZ Patients Read More »
